Market Tracker

09/02 4:54am ET

Northwest Biotherapeutics Inc (NASDAQ:NWBO)

5.84
Data as of Aug 29
 -0.03 / -0.51%
Today’s Change
3.10
Today|||52-Week Range
10.64
+54.91%
Year-to-Date
No recent news for Northwest Biotherapeutics Inc.

Today’s Trading

Previous close5.87
Today’s open5.96
Day’s range-- - --
Volume321,978
Average volume (3 months)1,018,300
Market cap$347.5M
Dividend yield--
Data as of 08/29/2014

Growth & Valuation

Earnings growth (last year)+65.03%
Earnings growth (this year)+8.50%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+4.79%
P/E ratioNM
Price/Sales153.15
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SCLNSciClone Pharmaceuti...+0.23+3.47%
PETXAratana Therapeutics...+0.14+1.22%
TTPHTetraphase Pharmaceu...+0.21+1.63%
XNCRXencor Inc+0.40+3.89%
Data as of 08/29/2014

Financials

Next reporting dateNovember 14, 2014
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$809.0K
Annual profit (last year)-$65.8M
Net profit margin-8,132.14%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, CEO, CFO &
CAO
Linda F. Powers
Chief Scientific Officer, Secretary &
Director
Alton L. Boynton
Corporate headquarters
Bethesda, Maryland

Forecasts